Cargando...
Factor VIII: Perspectives on Immunogenicity and Tolerogenic Strategies
Therapeutic treatment of bleeds with FVIII can lead to an antibody response that effectively inhibits its function. Herein, we review the factors that contribute to this immunogenicity and possible ways to overcome it.
Guardado en:
| Publicado en: | Front Immunol |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6978909/ https://ncbi.nlm.nih.gov/pubmed/32010137 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.03078 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|